MedPath

Prostate embolization for patients with symptomatic benign prostate hyperplasia: a prospective, single arm cohort study.

Recruiting
Conditions
benign prostate hyperplasia, BPH.
Registration Number
NL-OMON20499
Lead Sponsor
Terumo
Brief Summary

x

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

men > 40 years, with LUTS due to BPH, refrectory to medical therapy, Size > 50cc, IPSS > 18, Qol>2, Qmax<12.

Exclusion Criteria

malignancy prostate or bladder, neurogenic bladder, diverticula/calculi, urethra strictures, dysfunction bladderneck, eGRF < 30, prostatits, cystitis, atherosclerosis AII, allergy to i.v. contrast

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath